Template:Cholangiocarcinoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(14 intermediate revisions by 3 users not shown) | |||
Line 31: | Line 31: | ||
|- | |- | ||
! | ! | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
Line 47: | Line 46: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma causes|Causes]] | ||
|- | |- | ||
! | ! | ||
Line 53: | Line 52: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma differential diagnosis|Differentiating Cholangiocarcinoma from other Diseases]] | ||
|- | |- | ||
! | ! | ||
Line 59: | Line 58: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma epidemiology and demographics|Epidemiology and Demographics]] | ||
|- | |- | ||
! | ! | ||
Line 65: | Line 64: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma risk factors|Risk Factors]] | ||
|- | |- | ||
! | ! | ||
Line 71: | Line 70: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma screening|Screening]] | ||
|- | |- | ||
! | ! | ||
Line 77: | Line 76: | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
! | ! | ||
[[Cholangiocarcinoma natural history|Natural History, Complications | [[Cholangiocarcinoma natural history, complications and prognosis|Natural History, Complications and Prognosis]] | ||
|- | |- | ||
! | ! | ||
Line 89: | Line 88: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma history and symptoms|History | [[Cholangiocarcinoma diagnostic study of choice|Diagnostic Study of Choice]] | ||
|- | |||
! | |||
|- bgcolor="LightSkyBlue" | |||
! | |||
[[Cholangiocarcinoma history and symptoms|History and Symptoms]] | |||
|- | |- | ||
! | ! | ||
Line 101: | Line 106: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma laboratory tests| | [[Cholangiocarcinoma laboratory tests|Laboratory Findings]] | ||
|- | |- | ||
! | ! | ||
Line 113: | Line 118: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma x ray|X-ray]] | ||
|- | |- | ||
! | ! | ||
Line 131: | Line 136: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma echocardiography or ultrasound| | [[Cholangiocarcinoma echocardiography or ultrasound|Echocardiography or Ultrasound]] | ||
|- | |- | ||
! | ! | ||
Line 139: | Line 142: | ||
|- bgcolor="LightSkyBlue" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Cholangiocarcinoma other imaging findings | [[Cholangiocarcinoma other imaging findings|Other Imaging Findings]] | ||
|- | |- | ||
! | ! | ||
Line 150: | Line 149: | ||
! | ! | ||
[[Cholangiocarcinoma other diagnostic studies|Other Diagnostic Studies]] | [[Cholangiocarcinoma other diagnostic studies|Other Diagnostic Studies]] | ||
|- | |- | ||
! | ! | ||
Line 167: | Line 160: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma medical | [[Cholangiocarcinoma medical therapy|Medical Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 174: | Line 167: | ||
! | ! | ||
[[Cholangiocarcinoma surgery|Surgery]] | [[Cholangiocarcinoma surgery|Surgery]] | ||
|- | |- | ||
! | ! | ||
Line 181: | Line 172: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma primary prevention|Primary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 187: | Line 178: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma secondary prevention|Secondary Prevention]] | ||
|- | |- | ||
! | ! | ||
Line 193: | Line 184: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | ||
|- | |- | ||
! | ! | ||
Line 199: | Line 190: | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma future or investigational therapies|Future or Investigational Therapies]] | ||
|- | |||
! | |||
|- bgcolor="CadetBlue" | |||
! | |||
Case Studies | |||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleTurquoise" | |- bgcolor="PaleTurquoise" | ||
! | ! | ||
[[Cholangiocarcinoma | [[Cholangiocarcinoma case study one|Case #1]] | ||
|- | |- | ||
! | ! | ||
|- bgcolor="PaleGoldenrod " | |- bgcolor="PaleGoldenrod " |
Latest revision as of 17:50, 7 January 2019
Cholangiocarcinoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Cholangiocarcinoma On the Web |
American Roentgen Ray Society Images of Cholangiocarcinoma |